📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Understanding the rules of impermeability in Gram negative bacteria

Lead Research Organisation: UNIVERSITY OF BIRMINGHAM

Abstract

Modern medicine relies on being able to treat and prevent bacterial infection with antibiotics but the global crisis in antimicrobial resistance (AMR) means that these infections are becoming harder to treat. Most antibiotics must get inside bacteria to a certain concentration to kill them. Gram-negative bacteria, such as Salmonella and E. coli, are surrounded by a complex multi-layered cell envelope, which is a highly effective barrier that prevents antibiotics and other toxic molecules from entering the cell. These bacteria also have efflux pumps which export toxic molecules out of the cell. This Gram-negative cell envelope is a major determinant of AMR and remains the major hurdle to both the effective treatment of bacterial infection and the development of new antibiotics.
We have recently discovered that the mechanisms bacteria use to limit antibiotic  accumulation vary dramatically between different conditions. In particular, the relative importance of prevention of antibiotic entry, and pumping antibiotics outside the cell, changes depending on the physiological state of the bacteria and their environmental conditions. However, we still do not fully understand how different infection conditions influence antibiotic accumulation inside bacterial cells, what drives these changes, or how bacteria regulate this process.
This proposal will address these knowledge gaps by taking an interdisciplinary approach integrating expertise in bacterial efflux pumps, membrane biology, single cell analysis, antimicrobial accumulation, gene expression, metabolic changes and mathematics. We will develop new ways to measure how antibiotics get into cells and determine how this changes in different conditions relevant to infection. We will then be able to discover what cellular changes alter the level of antibiotic accumulation and how bacteria control this. Throughout, we will use data from these experiments to build and validate a mathematical model that we can use to decipher the Rules of Antibiotic Accumulation in Gram-negative bacteria. Mathematical models are capable of simulating thousands of experiments in minutes, meaning the results can be used to determine and accelerate an optimal experimental programme to achieve our goals. We will address some of the most important challenges in AMR including how to use existing antibiotics most effectively, how clinical diagnostics can better predict whether an infection is susceptible to an antibiotic, and to inform development of novel antimicrobials using host-mimicking conditions.
The proposed work directly addresses BBSRC strategic objectives in frontier bioscience and advancing understanding of the rules of life. Our findings will provide fundamental new insights into a critically important process with immediate relevance to antimicrobial development and broader implications for membrane transport across multiple sectors, including healthcare and industrial biotechnology.
The core objectives of this proposal are strengthened by secured institutional support, including funding for a cohort of aligned PhD students. These students will contribute to the project while benefiting from a rich training and research environment designed to develop a new generation of interdisciplinary researchers.
Training and career development are embedded as key priorities throughout this project. Through workshops, mentorship programmes, and opportunities for collaboration, we will cultivate an engaged and highly trained expert cohort of researchers prepared to address complex scientific challenges. This multidisciplinary team will drive innovation in antimicrobial research and beyond.
 

Publications

10 25 50